BSEInsider Trading / SAST26 Sept 2026 · 26 Sept 2026, 02:35 pm

Intimation of Trading Window closure for quarter and half year ending September 30, 2026

Kimia Biosciences Ltd · 530313

✦ AI SummaryResults

Kimia Biosciences Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half-year ended September 30, 2026, as per SEBI regulations.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Kimia Biosciences Ltd - 530313 - Closure of Trading Window

Attachments (1)

📄

99b41d80-8a21-4a0b-b9f2-5e39de3892d4.pdf

pdf

Download →
View document text
BSE Limited Ref: KIMIABL/COMP/BSE/2026-27 Corporate Relationship Department Date: 26 September 2026 Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400001 Scrip Code: 530313 Security ID: KIMIABL Subject: Intimation of Closure of Trading Window Dear Sir/Madam, Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, read with the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons, we hereby inform you that the Trading Window for dealing in the equity shares of the Company shall remain closed with effect from 1 October 2026 till the expiry of 48 (Forty-Eight) hours after the declaration of the Unaudited Financial Results of the Company for the quarter and half-year ended 30 September 2026. Accordingly, the Trading Window shall remain closed for all Promoters, Members of the Promoter Group, Directors, Designated Persons of the Company and their Immediate Relatives, and other persons covered under the Company's Code of Conduct. The date of the meeting of the Board of Directors for consideration and approval of the aforesaid financial results shall be intimated separately in due course in accordance with the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. You are requested to kindly take the above information on record. Thanking you, For Kimia Biosciences Limited Abhishek K. Pandey Company Secretary & Compliance Officer Membership No.: F12457 Place: Delhi compliance.kimiabiosciences@gmail.com | info@kimiabiosciences.com | www.kimiabiosciences.com | CIN No.:L24239HR1993PLC032120